Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Wave Life Sciences (WVE) Return on Sales (2016 - 2026)

Wave Life Sciences (WVE) has disclosed Return on Sales for 12 consecutive years, with 0.68% as the latest value for Q1 2026.

  • For Q1 2026, Return on Sales rose 443.0% year-over-year to 0.68%; the TTM value through Mar 2026 reached 3.91%, down 342.0%, while the annual FY2025 figure was 4.78%, 389.0% down from the prior year.
  • Return on Sales hit 0.68% in Q1 2026 for Wave Life Sciences, up from 11.43% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.15% in Q3 2023 and bottomed at 136.86% in Q3 2022.
  • Average Return on Sales over 5 years is 17.69%, with a median of 1.67% recorded in 2024.
  • Year-over-year, Return on Sales tumbled -13669bps in 2022 and then skyrocketed 13700bps in 2023.
  • Wave Life Sciences' Return on Sales stood at 0.54% in 2022, then skyrocketed by 76bps to 0.13% in 2023, then skyrocketed by 216bps to 0.15% in 2024, then crashed by -7898bps to 11.43% in 2025, then surged by 94bps to 0.68% in 2026.
  • According to Business Quant data, Return on Sales over the past three periods came in at 0.68%, 11.43%, and 0.56% for Q1 2026, Q4 2025, and Q3 2025 respectively.